AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency

被引:87
|
作者
Kung, Charles [1 ]
Hixon, Jeff [1 ]
Kosinski, Penelope A. [1 ]
Cianchetta, Giovanni [1 ]
Histen, Gavin [1 ]
Chen, Yue [1 ]
Hill, Collin [1 ]
Gross, Stefan [1 ]
Si, Yaguang [1 ]
Johnson, Kendall [1 ]
DeLaBarre, Byron [1 ]
Luo, Zhiyong [2 ]
Gu, Zhiwei [2 ]
Yao, Gui [2 ]
Tang, Huachun [2 ]
Fang, Cheng [2 ]
Xu, Yingxia [2 ]
Lv, Xiaobing [2 ]
Biller, Scott [1 ]
Su, Shin-San Michael [1 ]
Yang, Hua [1 ]
Popovici-Muller, Janeta [1 ]
Salituro, Francesco [1 ]
Silverman, Lee [1 ]
Dang, Lenny [1 ]
机构
[1] Agios Pharmaceut Inc, Cambridge, MA USA
[2] Shanghai ChemPartner Co Ltd, Shanghai, Peoples R China
关键词
NONSPHEROCYTIC HEMOLYTIC-ANEMIA; PK-LR GENE; RIBOFLAVIN TREATMENT; STEM-CELLS; ERYTHROCYTE; GENERATION; CANCER; ENZYME; MUTANT;
D O I
10.1182/blood-2016-11-753525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pyruvate kinase (PK) deficiency is a rare genetic disease that causes chronic hemolytic anemia. There are currently no targeted therapies for PK deficiency. Here, we describe the identification and characterization of AG-348, an allosteric activator of PK that is currently in clinical trials for the treatment of PK deficiency. We demonstrate that AG-348 can increase the activity of wild-type and mutant PK enzymes in biochemical assays and in patient red blood cells treated ex vivo. These data illustrate the potential for AG-348 to restore the glycolytic pathway activity in patients with PK deficiency and ultimately lead to clinical benefit.
引用
收藏
页码:1347 / 1356
页数:10
相关论文
共 50 条
  • [41] Red cell pyruvate kinase deficiency: from genetics to clinical manifestations
    Zanella, A
    Bianchi, P
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2000, 13 (01) : 57 - 81
  • [42] CHARACTERIZATION OF HEMATOPOIETIC SAMPLES FROM PYRUVATE KINASE DEFICIENCY PATIENTS
    Sanchez-Dominguez, R.
    Alberquilla, O.
    Lopez-Manzaneda, S.
    Quintana-Bustamante, O.
    Bianchi, P.
    Manu-Pereira, M. D. M.
    Vives-Corrons, J. -L.
    Badell, I.
    Sevilla, J.
    Bueren, J. A.
    Navarro, S.
    Segovia, J. C.
    HAEMATOLOGICA, 2017, 102 : 737 - 737
  • [43] LIFE-SPAN AND ORGAN SEQUESTRATION OF RED CELLS IN PYRUVATE KINASE DEFICIENCY
    NATHAN, DG
    OSKI, FA
    MILLER, DR
    GARDNER, FH
    NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (02): : 73 - &
  • [44] SPLENIC MACROPHAGE INTERACTION WITH RED CELLS IN PYRUVATE KINASE DEFICIENCY AND HEREDITARY SPHEROCYTOSIS
    BOWMAN, HS
    OSKI, FA
    VOX SANGUINIS, 1970, 19 (02) : 168 - &
  • [45] ANOMALOUS GLYCOLYSIS IN HEMOLYTIC ANEMIA DUE TO PYRUVATE KINASE DEFICIENCY OF RED CELLS
    CARTIER, P
    NAJMAN, A
    LEROUX, JP
    TEMKINE, H
    CLINICA CHIMICA ACTA, 1968, 22 (02) : 165 - &
  • [46] Mitapivat (AG-348) in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused: A Phase 3, Open-Label, Multicenter, Study (ACTIVATE-T) in Progress
    Lynch, Megan
    Hua, Lei
    Mix, Chris
    Porter, John B.
    BLOOD, 2019, 134
  • [47] RESEARCH ON MEMBRANE-LOCALIZED ERYTHROCYTIC PYRUVATE-KINASE IN PATIENTS WITH PYRUVATE-KINASE DEFICIENCY
    LAKOMEK, M
    WINKLER, H
    TILLMANN, W
    SCHROTER, W
    BLUT, 1980, 41 (04): : 285 - 285
  • [48] MOLECULAR-BASIS OF PYRUVATE-KINASE DEFICIENCY .2. ROLE OF THIOL-GROUPS IN PYRUVATE-KINASE FROM PYRUVATE KINASE-DEFICIENT PATIENTS
    VANBERKEL, TJ
    STAAL, GEJ
    KOSTER, JF
    NYESSEN, JG
    BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 334 (02) : 361 - 367
  • [49] PYRUVATE-KINASE ACTIVITY IN POTASSIUM-DEFICIENCY
    SOUTHON, S
    HEATON, FW
    IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1982, 10 (02): : 127 - 128
  • [50] Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study
    van Beers, Eduard J.
    van Straaten, Stephanie
    Morton, D. Holmes
    Barcellini, Wilma
    Eber, Stefan W.
    Glader, Bertil
    Yaish, Hassan M.
    Chonat, Satheesh
    Kwiatkowski, Janet L.
    Rothman, Jennifer A.
    Sharma, Mukta
    Neufeld, Ellis J.
    Sheth, Sujit
    Despotovic, Jenny M.
    Kollmar, Nina
    Pospisilova, Dagmar
    Knoll, Christine M.
    Kuo, Kevin
    Pastore, Yves D.
    Thompson, Alexis A.
    Newburger, Peter E.
    Ravindranath, Yaddanapudi
    Wang, Winfred C.
    Wlodarski, Marcin W.
    Wang, Heng
    Holzhauer, Susanne
    Breakey, Vicky R.
    Verhovsek, Madeleine
    Kunz, Joachim
    McNaull, Melissa A.
    Rose, Melissa J.
    Bradeen, Heather A.
    Addonizio, Kathryn
    Li, Anran
    Al-Sayegh, Hasan
    London, Wendy B.
    Grace, Rachael F.
    HAEMATOLOGICA, 2019, 104 (02) : E51 - E53